Vensana—Is Medtech Investing on the Rebound?

article image
ARTICLE SUMMARY:

After years that saw investors fleeing medical devices, a host of new funds and new entrants are breathing life into medtech start-ups. A case in point: Vensana Capital, a $225 million fund recently launched by industry veterans Kirk Nielsen and Justin Klein.

Just a few years ago, the question, “Why would anyone want to start anew fund in medtech?” would have been deemed rhetorical, with a clear implication that no one would.Indeed, not only were few VCs coming new into the space, many established medtech investors were scaling back or leaving altogether.

×

This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: